Judgment of the General Court (Sixth Chamber), 22 January 2015
Teva Pharma BV and Teva Pharmaceuticals Europe BV v European Medicines Agency (EMA)
Medicinal products for human use — Orphan medicinal products — Application for marketing authorisation for the generic version of the orphan medicinal product imatinib — EMA decision refusing to validate the application for marketing authorisation — Market exclusivity
Case T‑140/12
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Judgment
ECLI:EU:T:2015:41 |
|
|
|